Generics 49

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cisplatin manufacturers

49 products found

Filters

49 products found

cisplatin

Concentrate for solution for infusion 0.5mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Germany
Available for
Licensing with supply, Distribution only
Manufacturer #16717
They've been serving and assisting customers in the healthcare business in Regulatory Affairs and Pharmacovigilance for over 30 years. This sphere of action covers many countries around the world. They look after their local and European consumers and the supply chain by providing high-quality products for internationalization strategies.

Manufacturer usually replies in 14 days

cisplatin

Concentrate for solution for infusion 1 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Turkey , Vietnam , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

cisplatin

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

cisplatin

Vials, injection 10 mg/10 ml, 50 mg/50 ml, 25 mg/25 ml, 100 mg/100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

cisplatin

Solution for injection single dose Vial

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #12319

Manufacturer usually replies in 5 days

cisplatin

Injection 10 mg , 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

cisplatin

Injection 10 mg, 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19783

Manufacturer usually replies in 2 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

cisplatin

Vials, injection 50mg/50ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #16899
The deed of incorporation was signed in the 2000s to research substances and goods that may be added to the product range. With the support of sales personnel from the pharma line, a range of dermo-cosmetic goods was developed over time. Later, it was considered that two independent lines would be best to avoid misunderstanding in medical activities, therefore the pharmaceutical and dermo-cosmetic divisions were formed.

Manufacturer usually replies in 2 days

cisplatin

Solution for injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

cisplatin

Solution for infusion Single dose Vial

Dossier type
CTD
Dossier status
Country of origin
India
GMP approvals
WHO
Manufacturer #12319

Manufacturer usually replies in 5 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21110

Manufacturer usually replies in 6 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #20956
It is specialized in the human healthcare field, and has been manufacturing, marketing, and selling pharmaceutical products since the 1980s. They have a broad range of products from OTC, ETC including about 30 kinds of anti-cancer products.

Manufacturer usually replies in 8 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

cisplatin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

cisplatin

Vials, injection 10 mg / 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, INVIMA
Manufacturer #18529

Manufacturer usually replies in 8 days

cisplatin

Injection 10 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

cisplatin

Vials, injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17691

Manufacturer usually replies in 7 days

Want to view all 49 products? Create your free account today!

Cisplatin Manufacturer

Cisplatin is the generic name for a platinum-based chemotherapy drug that is marketed under the brand name Platinol. Cisplatin is an antineoplastic drug used to treat cancers such as sarcoma, carcinoma, lymphoma, and germ cell tumors. This pharmaceutical medicine is classified as an alkylating agent. This pharmaceutical remedy is contraindicated in patients with renal impairment and myelosuppressive patients. It should not be administered in patients with hypersensitivity or those who show allergic reactions to platinum-based compounds. The most common side effects of Cisplatin include nausea, vomiting (may be severe), diarrhea, temporary hair loss, loss of taste sense, hiccups, dry mouth, dark urine, decreased sweating, and dry skin. Some of the serious and severe side effects include; numbness and tingling sensation in hand and feet, swelling of arms or legs, loss of reflexes, loss of balance, irregular heartbeat, hematuria, black or bloody stool, vision changes (seeing colors differently), and blurred vision. The drug is administered intravenously to patients and is sold in vials as Cisplatin manufacturers concentrate on intravenous infusion or in a powder that can be diluted into an intravenous solution. In 1978, the FDA approved this pharmaceutical drug for the treatment of advanced ovarian and bladder cancer. This pharmaceutical medicine is contraindicated during pregnancy. The drug has the potential to harm the fetus as the medication crosses the placenta, which can also result in preterm birth. This pharmaceutical medicine may be harmful to a nursing infant as it may have an adverse effect on the normal microbiome and chemical composition of breastmilk.

How does Cisplatin work?

Cisplatin slows tumor growth by targeting DNA directly. Guanine nucleotides in DNA double-helix strands are crosslinked by alkylating chemicals. The threads are still unable to unravel and split as a result. The cells could no more multiply as this is essential for the Replication of DNA. Alkylating agencies work through three mechanisms: 1) the attachment of alkyl groups to DNA bases, causing DNA to be fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA; 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA), preventing DNA from being separated for synthesis or transcription; and 3) the induction of nucleotide mispairing. Cisplatin is an anticancer drug that belongs to the alkylating agent class. It is used to treat a variety of cancers. Alkylating agents get their name from their capacity to add a methyl group to a variety of electronegative groups in cells. They limit tumor growth by directly damaging DNA bypass guanine nucleotides in double-helix strands. The strands are unable to unravel and split as a result of this. The cells can no longer divide because this is essential for DNA replication. Furthermore, these medications introduce methyl or other alkyl groups into molecules so they do not fit, preventing proper base pairing and resulting in DNA Skilton - Sylvester. Alkylating chemicals operate through three separate methods, all of which result in the same end consequence: disruption of DNA function and cell death. Cisplatin, the basic chemical, is eliminated in the urine. Despite the presence of tiny levels of platinum in the bile and big intestine after cisplatin administration, fecal platinum excretion seems to be minimal.

Common Side Effects

Suppression of bone marrow, hearing issues, kidney damage, and vomiting are all common adverse effects. Numbness, difficulty walking, allergic responses, electrolyte issues, and heart disease are some of the other major side effects. It's possible that using it while pregnant will harm the baby. Cisplatin belongs to the platinum-based anticancer drug class. Platinum contents are highest in the liver, prostate, and kidney after cisplatin doses of 20 to 120 mg/m2, slightly lower in the bladder, muscle, testis, pancreas, and spleen, and least in the colon, adrenal, brain, lung, forebrain, and cerebellum. Platinum can stay in the body for up to 180 days after it has been administered.

The Cost of Cisplatin

Cisplatin intravenous solution (1 mg/mL) costs roughly $16 for a 50-milliliter dose. But the prices might vary as per the pharmacy location you visit or the distributor you buy from. Wholesale price differs according to the wholesaler of the region or country where the order has been processed for sale. The global list of manufacturers, suppliers, and distributors is long. There is currently no generic counterpart; it is only available as a brand-name drug. For more information, read about the generic Cisplatin availability. Pharmaceutical companies typically support patient development programs, which offer low-income, jobless, or underemployed healthcare personnel with free or subsidized drugs if they meet certain criteria.

Navigating our Pharmaceutical Marketplace

Pipelinepharma is a B2B online marketplace that simplifies pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Cisplatin offerings can be narrowed down with the use of filters and easily weighed against one another according to wholesale medication prices and commercial terms. The advanced filters help you filter out the countries for these Cisplatin manufacturers and these Cisplatin suppliers that you are looking for. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Cisplatin is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial ties

Pipelinepharma provides a platform for drug retailers and buyers where they can sell and purchase drugs. Furthermore, people holding pharmaceutical licenses can enroll themselves and can publicize as many drugs as they would like.

Quality assurance

Pipelinepharma ensures that only validated Cisplatin manufacturers, Cisplatin suppliers, Cisplatin distributors, and Cisplatin wholesalers list enter their advertising platform through their pre-auditing and quality control operations, providing a safe B2B pharmaceutical sales platform.